Can more proton radiation beat lung cancer safely?
NCT ID NCT06484491
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether giving a higher dose of proton therapy to the lung tumor is safe for people with stage III non-small-cell lung cancer who are also getting chemotherapy. About 87 participants will receive the higher radiation dose along with standard chemo drugs. Researchers will monitor for severe side effects needing hospital care and check how well the treatment controls the tumor.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Proton therapy (radiation) plus cisplatin or carboplatin with pemetrexed and docetaxel (chemotherapy)
What this could lead to
If successful, this could show that a higher dose of proton therapy is safe and may improve tumor control for people with advanced lung cancer.
What could go wrong
This is a small early pilot study with only 87 participants, so results may not apply to everyone. There is a risk of severe side effects from the higher radiation dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UMCG
RECRUITINGGroningen, Netherlands